Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature medicine 2020-05, Vol.26 (5), p.803-803
Hauptverfasser:	Brudno, Jennifer N., Lam, Norris, Vanasse, Danielle, Shen, Yueh-wei, Rose, Jeremy J., Rossi, John, Xue, Allen, Bot, Adrian, Scholler, Nathalie, Mikkilineni, Lekha, Roschewski, Mark, Dean, Robert, Cachau, Raul, Youkharibache, Philippe, Patel, Rashmika, Hansen, Brenna, Stroncek, David F., Rosenberg, Steven A., Gress, Ronald E., Kochenderfer, James N.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250 631/250/251 692/308 692/308/2779/109/1940 692/308/575 692/699/67/1059/2325 692/699/67/1990/291 Author Correction B-cell lymphoma Biomedical and Life Sciences Biomedicine Cancer Research Care and treatment CD19 antigen Infectious Diseases Lymphocytes Lymphocytes B Lymphocytes T Lymphoma Lymphomas Metabolic Diseases Molecular Medicine Neurosciences T cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An amendment to this paper has been published and can be accessed via a link at the top of the paper.
ISSN:	1078-8956 1546-170X
DOI:	10.1038/s41591-020-0864-x